Smart cap aims to boost medication adherence in lung disease patients

NCT ID NCT07613216

First seen May 29, 2026 · Last updated Jun 17, 2026 · Updated 3 times

Summary

This study will test if a smart pill bottle cap, called FORTISKAP™, helps people with serious lung diseases like pulmonary fibrosis, sarcoidosis, and pulmonary hypertension take their oral medications more consistently. About 100 participants will either use the smart cap or receive usual care for nine months. The goal is to see if the device improves medication adherence and leads to better health outcomes, such as walking distance and lung function.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PULMONARY HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Pulmonary Disease Clinic, Sentara Norfolk Hospital

    Norfolk, Virginia, 23507, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

The condition(s) this trial relates to.

idiopathic pulmonary fibrosis interstitial lung disease interstitial lung disease 2 Medication Adherence pulmonary hypertension pulmonary sarcoidosis sarcoidosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.